Samples with either TRPV4 (Fig. 3a), KRAS (Fig. 3b), or FGFR1 (Fig. 3c) mutations had strong phospho-ERK staining in a large component of the mononuclear cells in the tumor, while the multinucleated giant cells were negative, as expected. This evidence concerns the gene FGFR1 and neoplasm.